NCT00834977View on ClinicalTrials.gov

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Healthy
Interventions
DRUG

Amlodipine-benazepril 10 mg-20 mg capsules

1 x 10-20 mg

DRUG

Lotrel® 10 mg-20 mg capsule

1 x 10-20 mg

Trial Locations (2)

H3X H29

Anapharm Inc., Montreal

G1V 2K8

SFBC Anapharm, Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00834977 - Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter